- Rise in tourist footfall, international airport, Vande Bharat Express: How Ram Mandir is becoming the development centre for Ayodhya OpIndia
- Ram Temple idol consecration ceremony: From Dalai Lama to Rajinikanth to Adani, guest list to include people from all walks of life The Indian Express
- Temple promised by BJP transforms India’s Ayodhya but Muslims, some locals feel neglected Reuters India
- Invites sent to guests for temple consecration ceremony in Ayodhya, says senior Ram Mandir Trust official The Hindu
- Advani, Joshi may skip temple event due to age, health issues IndiaTimes
Tag Archives: Bharat
India’s government replaces ‘India’ with ancient name ‘Bharat’ in dinner invitation to G20 guests – Yahoo News
- India’s government replaces ‘India’ with ancient name ‘Bharat’ in dinner invitation to G20 guests Yahoo News
- India’s Modi gov’t replaces country’s name with Bharat in G20 dinner invite Al Jazeera English
- Mindgames To Trump ‘INDIA’ Group? Political Bomb Detonates On India India Today
- India or Bharat? President’s G20 dinner invitation sparks name-change row Reuters India
- India’s government replaces ‘India’ with ancient name ‘Bharat’ in dinner invitation to G20 guests The Associated Press
- View Full Coverage on Google News
‘When Modi says Cong-mukt Bharat, does he mean…’: Udhayanidhi amid row – Hindustan Times
- ‘When Modi says Cong-mukt Bharat, does he mean…’: Udhayanidhi amid row Hindustan Times
- Tamil Nadu BJP Chief Annamalai Reacts To Udhayanidhi Stalin’s Anti-Sanatan Speech India Today
- MK Stalin’s Son’s “Sanatana Dharma” Remark Sparks Row | Left, Right & Centre NDTV
- Udhayanidhi Stalin’s call for Hindu genocide does BJP a big favour in Tamil Nadu Firstpost
- Udhayanidhi’s ‘eradicate Sanatana’ not a call to genocide. It’s internal critique of Hinduism ThePrint
- View Full Coverage on Google News
Box office battle: Gadar 2 crosses Rs 500 cr mark on day 24, falls a little short of breaking Pathaan record; OMG 2 remains steady – ETV Bharat
- Box office battle: Gadar 2 crosses Rs 500 cr mark on day 24, falls a little short of breaking Pathaan record; OMG 2 remains steady ETV Bharat
- Gadar 2 box office collection day 23: Film all set to breach ₹500 crore mark Hindustan Times
- Gadar 2 inches closer to the Rs 500 crore club; Dream Girl 2 has a shot at hitting a century PINKVILLA
- Anil Sharma aspires to submit Gadar 2 for the Oscars; says, “Gadar: Ek Prem Katha also deserved it” Bollywood Hungama
- Indian BO Report: ‘Gadar 2’ Inches Close To $80 Million, ‘Jailer’ Crosses $75 Million Forbes
- View Full Coverage on Google News
World’s first malaria vaccine: GAVI to launch 18 million doses in 12 countries, know how India’s Bharat Biotech and Serum Institute are going to play a crucial role – OpIndia
- World’s first malaria vaccine: GAVI to launch 18 million doses in 12 countries, know how India’s Bharat Biotech and Serum Institute are going to play a crucial role OpIndia
- 9 African Countries To Receive Millions Of Malaria Fever Vaccines + More | Network Africa Channels Television
- Nine new African countries to be given malaria vaccines The Irish Times
- African Countries to Get 18 Million Doses of First-Ever Malaria Vaccine AllAfrica – Top Africa News
- Africa to receive 18 million doses of malaria vaccine Reuters
- View Full Coverage on Google News
Bharat Biotech To Get $19 Million For Development Of ‘Variant Proof’ Covid Vaccine
CEPI will fund the initiative under its USD 200 million programme to advance the development of vaccines
New Delhi:
The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a “variant-proof” SARS-CoV-2 vaccine candidate.
CEPI will fund the initiative under its USD 200 million programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other betacoronaviruses.
The funding will support the consortium as it seeks to establish preclinical and clinical proof of concept for an adjuvanted subunit vaccine designed to provide broad protection against all known SARS-CoV-2 variants of concern, as well as future variants of the virus which have not yet emerged.
CEPI will fund the researchers to conduct activities including immunogen design, preclinical studies, manufacturing process development and a Phase 1 clinical trial.
“As repeated waves of COVID-19 infection remind us, we will be living alongside the virus for many years to come. The threat of a new variant emerging that might evade the protection of our current vaccines is real, so investing in R&D for variant-proof SARS-CoV-2 vaccines is a global health security imperative,” CEPI CEO Richard Hatchett said.
He further said: “Our partnership with Bharat Biotech, University of Sydney and ExcellGene will advance the development of a vaccine candidate to protect against future variants of COVID-19, potentially contributing to the long-term control of the virus.” Bharat Biotech Chairman and Managing Director Krishna Ella said while the current vaccines are safe and effective against presently known variants, it is imperative that there is a focus on innovation for multi-epitope vaccines, where a single vaccine can protect against all future variants.
“Our expertise in product development and innovation, especially with novel adjuvants and platform technologies will add to the strong partnership with CEPI, ExcellGene, and the University of Sydney,” he added.
CEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to develop vaccines against future epidemics.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
India’s Bharat Biotech says vaccine 93.4% effective against severe COVID-19
July 3 (Reuters) – Phase-III trials of a vaccine made by India’s Bharat Biotech showed it was 93.4% effective against severe symptomatic COVID-19, the firm said on Saturday, a finding that could boost people’s acceptance of Covaxin.
The data demonstrated 65.2% protection against the Delta variant, first identified in India, that led to a surge in infections in April and May, and the world’s highest daily death tolls.
India’s homegrown vaccine also showed effectiveness of 77.8% against symptomatic COVID-19 in the trial.
Last month, vaccine maker AstraZeneca Plc (AZN.L) also said its vaccine was effective against the Delta and Kappa variants, citing a study.
India has been administering the AstraZeneca vaccine, made domestically by the Serum Institute of India, which said last month it planned to step up monthly production from July, to nearly 100 million doses.
Bharat Biotech now estimates it will make 23 million doses a month.
The Phase-III data came as Ocugen Inc (OCGN.O), which is co-developing Covaxin with Bharat Biotech for the U.S. market, prepares to file a request for full U.S. approval.
India, with a tally of 30.45 million infections, is the second most affected nation after the United States, with 33 million. The south Asian nation’s death toll has now crossed 400,000.
Reporting by Maria Ponnezhath in Bengaluru; Editing by Clarence Fernandez
Our Standards: The Thomson Reuters Trust Principles.
Bharat Narumanchi: Pediatrician fatally shoots another doctor and himself during hostage situation in Austin, Texas police say
Dispatchers received a call on Tuesday saying a man walked into the offices of Children’s Medical Group with a gun and was holding hostages inside the building.
Initially several hostages were being held, police said, but several escaped and others were allowed to leave, except Dr. Katherine Dodson, a pediatrician at CMG. Hostages told officers the man was armed with with a pistol and what appeared to be a shotgun, police said. He also had two duffel bags.
The armed man was identified as Dr. Bharat Narumanchi, 43, a pediatrician who was recently diagnosed with terminal cancer, police said. Records show he had resided in multiple states and that his last state of residence was California.
He had visited the CMG office a week prior to the shooting and applied for a volunteer position, police said. Other than his recent visit, police were unable to find a connection between Dodson and Narumanchi.
Hostage negotiators then arrived on scene and tried to make contact with Narumanchi, but were unsuccessful. After repeated attempts, SWAT officers entered the building where they found Dodson and Narumanchi dead from apparent gunshot wounds.
“It appeared that Dr. Narumanchi shot himself after shooting Dr. Dodson,” according to the police department’s news release. The incident is still under investigation.
The Travis County Medical Examiner will be conducting an autopsy to determine the official cause and manner of death.
Flowers draped the sign of CMG Wednesday as the community mourned Dodson’s death, according to CNN affiliate KEYE-TV.
Dodson, 43, joined CMG as a pediatrician in 2017, the medical center’s website said. She was a native of Baton Rouge, Louisiana, and was married with three children, the website said.
“She has the nicest bedside manner,” Michelle Sweitzer told KEYE-TV. “She tells your children, ‘I love you’ and puts them at ease and is the sweetest, kindest caring doctor.”